These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29702240)

  • 1. Redox-responsive microbeads containing thiolated pectin-doxorubicin conjugate inhibit tumor growth and metastasis: An in vitro and in vivo study.
    Cheewatanakornkool K; Niratisai S; Dass CR; Sriamornsak P
    Int J Pharm; 2018 Jul; 545(1-2):1-9. PubMed ID: 29702240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiolated pectin-doxorubicin conjugates: Synthesis, characterization and anticancer activity studies.
    Cheewatanakornkool K; Niratisai S; Manchun S; Dass CR; Sriamornsak P
    Carbohydr Polym; 2017 Oct; 174():493-506. PubMed ID: 28821097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
    Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
    Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and
    Cheewatanakornkool K; Niratisai S; Manchun S; Dass CR; Sriamornsak P
    Asian J Pharm Sci; 2017 Nov; 12(6):509-520. PubMed ID: 32104364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
    Shamay Y; Golan M; Tyomkin D; David A
    J Control Release; 2016 May; 229():192-199. PubMed ID: 27001892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer.
    Manchun S; Dass CR; Cheewatanakornkool K; Sriamornsak P
    Carbohydr Polym; 2015 Aug; 126():222-30. PubMed ID: 25933543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts.
    Gazzano E; Buondonno I; Marengo A; Rolando B; Chegaev K; Kopecka J; Saponara S; Sorge M; Hattinger CM; Gasco A; Fruttero R; Brancaccio M; Serra M; Stella B; Fattal E; Arpicco S; Riganti C
    Cancer Lett; 2019 Aug; 456():29-39. PubMed ID: 31047947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbeads mediated oral plasmid DNA delivery using polymethacrylate vectors: an effectual groundwork for colorectal cancer.
    Bhatt P; Khatri N; Kumar M; Baradia D; Misra A
    Drug Deliv; 2015; 22(6):849-61. PubMed ID: 24725027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular delivery of doxorubicin mediated by disulfide reduction of a peptide-dendrimer bioconjugate.
    Burns KE; Delehanty JB
    Int J Pharm; 2018 Jul; 545(1-2):64-73. PubMed ID: 29709616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy.
    Lee CS; Kim H; Yu J; Yu SH; Ban S; Oh S; Jeong D; Im J; Baek MJ; Kim TH
    Eur J Med Chem; 2017 Dec; 142():416-423. PubMed ID: 28870452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated pH/redox dual-sensitive and hepatoma-targeted multifunctional polymeric micelle system for stimuli-triggered doxorubicin release: Synthesis, characterization and in vitro evaluation.
    Wang L; Tian B; Zhang J; Li K; Liang Y; Sun Y; Ding Y; Han J
    Int J Pharm; 2016 Mar; 501(1-2):221-35. PubMed ID: 26851356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous silica coated gold nanorods loaded doxorubicin for combined chemo-photothermal therapy.
    Monem AS; Elbialy N; Mohamed N
    Int J Pharm; 2014 Aug; 470(1-2):1-7. PubMed ID: 24792973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A54 Peptide Modified and Redox-Responsive Glucolipid Conjugate Micelles for Intracellular Delivery of Doxorubicin in Hepatocarcinoma Therapy.
    Liu N; Tan Y; Hu Y; Meng T; Wen L; Liu J; Cheng B; Yuan H; Huang X; Hu F
    ACS Appl Mater Interfaces; 2016 Dec; 8(48):33148-33156. PubMed ID: 27934140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
    Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
    Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma.
    Qiu R; Sun D; Bai Y; Li J; Wang L
    Drug Deliv; 2020 Nov; 27(1):1704-1717. PubMed ID: 33305647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.
    Mou Q; Ma Y; Zhu X; Yan D
    J Control Release; 2016 May; 230():34-44. PubMed ID: 27040815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.